Primaquine, currently the only hypnozoicidal drug specified in Guyana’s National Treatment Guidelines, must be taken daily for 2 weeks and requires prior glucose-6-phosphate dehydrogenase deficiency assessment of hemolysis risk. The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.